Cyclin-dependent kinases as therapeutic targets for HIV-1 infection
10.1080/14728222.2016.1254619 · doi-reference
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation
10.1172/jci39199 · doi-reference
Dual effect of the broad spectrum kinase inhibitor midostaurin in acute and latent HIV-1 infection
10.1016/j.antiviral.2019.05.003 · doi-reference
Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4+ T cells ex vivo
10.1126/sciadv.aba1941 · doi-reference
HIV latency: should we shock or lock?
10.1016/j.it.2016.12.003 · doi-reference
Shock and kill
10.1038/487439a · doi-reference
Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines
10.1128/jvi.73.7.5422-5430.1999 · doi-reference
Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection
10.1128/jvi.73.5.4101-4109.1999 · doi-reference
HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells
10.1016/j.celrep.2022.110650 · doi-reference
Bimodal expression patterns, and not viral burst sizes, predict the effects of Vpr on HIV-1 proviral populations in jurkat cells
10.1128/mbio.03748-21 · doi-reference
HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells
10.1371/journal.ppat.1013073 · doi-reference
Subversion of cell cycle regulatory mechanisms by HIV
10.1016/j.chom.2015.05.010 · doi-reference
Viral mechanisms of immune evasion
10.1016/s1357-4310(00)01775-5 · doi-reference
Viral evasion of intracellular DNA and RNA sensing
10.1038/nrmicro.2016.45 · doi-reference
Decoding type I and III interferon signalling during viral infection
10.1038/s41564-019-0421-x · doi-reference
Cell cycle arrest in G2/M phase enhances replication of interferon-sensitive cytoplasmic RNA viruses via inhibition of antiviral gene expression
10.1128/jvi.01885-18 · doi-reference
HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages
10.1038/s41467-024-49635-w · doi-reference
Global post-translational modification profiling of HIV-1-infected cells reveals mechanisms of host cellular pathway remodeling
10.1016/j.celrep.2022.110690 · doi-reference
HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation
10.1016/j.virol.2007.10.042 · doi-reference
Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells
10.4049/jimmunol.165.6.3293 · doi-reference
Genetic instability from a single S phase after whole-genome duplication
10.1038/s41586-022-04578-4 · doi-reference
Sublinear scaling of the cellular proteome with ploidy
10.1038/s41467-022-33904-7 · doi-reference
Extensive protein dosage compensation in aneuploid human cancers
10.1101/gr.276378.121 · doi-reference
Context-dependent effects of whole-genome duplication during mammary tumor recurrence
10.1038/s41598-021-94332-z · doi-reference
HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B
10.1038/nm1097-1117 · doi-reference
Induction of apoptosis by the Vpr protein of human immunodeficiency virus type 1 occurs independently of G(2) arrest of the cell cycle
10.1006/viro.2000.0534 · doi-reference
Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest
10.1128/jvi.71.7.5579-5592.1997 · doi-reference
HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator
10.1073/pnas.95.9.5281 · doi-reference
Studying retroviral life cycles using visible viruses and live cell imaging
10.1146/annurev-virology-100422-012608 · doi-reference
The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H
10.1128/jvi.06082-11 · doi-reference
Single-cell delineation of strain-specific HIV-1 Vif activities using dual reporter sensor cells and live cell imaging
10.1128/jvi.01579-24 · doi-reference
Demystifying cell cycle arrest by HIV-1 Vif
10.1016/j.tim.2021.01.001 · doi-reference
Aurora B phosphorylates centromeric MCAK and regulates its localization and microtubule depolymerization activity
10.1016/j.cub.2004.01.055 · doi-reference
Aurora kinase promotes turnover of kinetochore microtubules to reduce chromosome segregation errors
10.1016/j.cub.2006.07.022 · doi-reference
The Aurora kinase family in cell division and cancer
10.1016/j.bbcan.2008.07.003 · doi-reference
PP2A as a master regulator of the cell cycle
10.3109/10409238.2016.1143913 · doi-reference
Functional and structural insights into a Vif/PPP2R5 complex elucidated using patient HIV-1 isolates and computational modeling
10.1128/jvi.00631-20 · doi-reference
The ATM-related kinase, hSMG-1, bridges genome and RNA surveillance pathways
10.1016/j.dnarep.2004.04.003 · doi-reference
HIV-1 Vif promotes the G1- to S-phase cell-cycle transition
10.1182/blood-2010-06-289215 · doi-reference
HIV-1 Vif’s capacity to manipulate the cell cycle is species specific
10.1128/jvi.02102-17 · doi-reference
